NCT04165070 · Interventional trial
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Carcinoma, Non-Small-Cell Lung
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania ( Site 0010) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory